Relative Bioavailability and Food Effect Study
NCT01489488
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class
Conditions
Pharmacology, Clinical
Interventions
DRUG:
Riociguat (BAY63-2521)
DRUG:
Riociguat (BAY63-2521)
DRUG:
Riociguat (BAY63-2521)
DRUG:
Riociguat (BAY63-2521)
DRUG:
Riociguat (BAY63-2521)
Sponsor
Bayer